FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
作者： Ravit Geva , Loredana Vecchione , Konstantinos T Kalogeras , Benny Vittrup Jensen , Heinz-Josef Lenz
DOI: 10.1136/GUTJNL-2014-307234
关键词:
摘要: Objective We aimed to better clarify the role of germline variants of the FCG2 receptor, FCGR2A-H131R and FCGR3A-V158F, on the therapeutic efficacy of cetuximab in metastatic …
sci-hub.se 参考文章(29)
Xiao-Ming Jiang, Gow Arepally, Mortimer Poncz, Steven E. McKenzie, Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). Journal of Immunological Methods. ,vol. 199, pp. 55- 59 ,(1996) , 10.1016/S0022-1759(96)00164-0
Wen-Kai Weng, Ronald Levy, Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma Journal of Clinical Oncology. ,vol. 21, pp. 3940- 3947 ,(2003) , 10.1200/JCO.2003.05.013
N.M. Van Sorge, W-L. Van Der Pol, J.G.J. Van De Winkel, FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens. ,vol. 61, pp. 189- 202 ,(2003) , 10.1034/J.1399-0039.2003.00037.X
Jan Pander, Hans Gelderblom, Ninja F. Antonini, Jolien Tol, Johan H.J.M. van Krieken, Tahar van der Straaten, Cornelis J.A. Punt, Henk-Jan Guchelaar, Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer. European Journal of Cancer. ,vol. 46, pp. 1829- 1834 ,(2010) , 10.1016/J.EJCA.2010.03.017
Manfred Ahlgrimm, Michael Pfreundschuh, Markus Kreuz, Evi Regitz, Klaus-Dieter Preuss, Joerg Bittenbring, The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab Blood. ,vol. 118, pp. 4657- 4662 ,(2011) , 10.1182/BLOOD-2011-04-346411
Yoshiaki Tsuchida, Patrick Therasse, Response evaluation criteria in solid tumors (RECIST): new guidelines. Medical and Pediatric Oncology. ,vol. 37, pp. 1- 3 ,(2001) , 10.1002/MPO.1154
Yoshiki Itoh, Nobuhisa Mizuki, Tsuyako Shimada, Fumihiro Azuma, Mitsuo Itakura, Koichi Kashiwase, Eri Kikkawa, Jerzy K. Kulski, Masahiro Satake, Hidetoshi Inoko, High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics. ,vol. 57, pp. 717- 729 ,(2005) , 10.1007/S00251-005-0048-3
Javier Rodríguez, Ruth Zarate, Eva Bandres, Valentina Boni, Amaia Hernández, Jesus Javier Sola, Beatriz Honorato, Nerea Bitarte, Jesus García-Foncillas, Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer. European Journal of Cancer. ,vol. 48, pp. 1774- 1780 ,(2012) , 10.1016/J.EJCA.2012.01.007
D Paez, I Espinosa, A Altés, E del Rio, J Salazar, A Barnadas, E Marcuello, M Baiget, Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy? Cancer Science. ,vol. 101, pp. 2048- 2053 ,(2010) , 10.1111/J.1349-7006.2010.01621.X
F.G.J Leppers-van de Straat, W-L van der Pol, M.D Jansen, N Sugita, H Yoshie, T Kobayashi, J.G.J van de Winkel, A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping Journal of Immunological Methods. ,vol. 242, pp. 127- 132 ,(2000) , 10.1016/S0022-1759(00)00240-4